SY
So-Young International Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · CN
$2.76
−2.13%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.8B | 1.5B | 1.5B | 1.5B | 1.3B |
| Cost of Revenue | 987.3M | 774.0M | 567.6M | 544.3M | 393.3M |
| Gross Profit | 787.7M | 707.9M | 899.1M | 953.7M | 864.6M |
| Operating Expenses | |||||
| R&D Expense | 97.4M | 133.3M | 165.0M | 203.5M | 235.1M |
| SG&A Expense | 941.5M | 833.8M | 818.6M | 811.2M | 732.3M |
| General & Admin Expense | 88.6M | — | 324.1M | 290.8M | 260.2M |
| Selling & Marketing Expense | 130.7M | — | 494.5M | 520.5M | 472.1M |
| Other Expenses | 24.3M | 6.99 | 540.0M | — | — |
| Total Operating Expenses | 1.1B | 967.1M | 1.5B | 1.0B | 967.4M |
| Cost and Expenses | 2.1B | 1.7B | 2.1B | 1.6B | 1.4B |
| Operating Income (EBIT) | (275.6M) | (259.2M) | (624.5M) | (61.0M) | (102.8M) |
| Non-Operating | |||||
| Interest Income | 20.3M | 24.6M | 46.5M | 48.8M | 28.9M |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 20.3M | 24.6M | 46.5M | 48.8M | 28.9M |
| Other Non-Op Income/Expense | 21.0M | 19.8M | 36.4M | 68.9M | 15.7M |
| Non-Operating Income (excl Interest) | (4.6M) | (19.8M) | (540.0M) | (68.9M) | (15.7M) |
| EBT (Pre-Tax Income) | (254.6M) | (239.4M) | (588.1M) | 7.9M | (87.1M) |
| Income Tax Expense | (2.7M) | (774.3K) | (905.0K) | (18.1M) | (21.0M) |
| Bottom Line | |||||
| Net Income | (243.1M) | (235.7M) | (589.5M) | 21.3M | (65.6M) |
| Earnings from Cont. Ops | (251.9M) | (238.6M) | (587.2M) | 25.9M | (66.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (243.1M) | (235.7M) | (589.5M) | 21.3M | (65.6M) |
| Per Share | |||||
| Basic EPS | ($1.84) | ($1.78) | ($4.40) | $0.16 | ($0.48) |
| Diluted EPS | ($1.84) | ($1.78) | ($4.39) | $0.16 | ($0.48) |
| Revenue Per Share | $13.50 | $11.26 | $10.94 | $11.36 | $9.11 |
| Shares | |||||
| Basic Shares Outstanding | 131.5M | 131.6M | 134.1M | 131.9M | 138.0M |
| Diluted Shares Outstanding | 131.5M | 131.6M | 134.2M | 131.9M | 138.0M |
| Profitability Metrics | |||||
| EBITDA | (213.8M) | (182.2M) | (38.4M) | 54.0M | (40.0M) |
| D&A | 57.2M | 57.2M | 46.1M | 46.1M | 47.1M |
| EBIT | (271.0M) | (239.4M) | (84.5M) | 7.9M | (87.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026